BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25168242)

  • 1. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.
    Ayroldi E; Petrillo MG; Bastianelli A; Marchetti MC; Ronchetti S; Nocentini G; Ricciotti L; Cannarile L; Riccardi C
    Cell Death Differ; 2015 Jan; 22(1):118-30. PubMed ID: 25168242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel partnership of L-GILZ and p53: a new affair in cancer?
    Ayroldi E; Marchetti C; Riccardi C
    Mol Cell Oncol; 2015; 2(2):e975087. PubMed ID: 27308427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
    Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
    J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
    Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
    Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
    Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
    PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
    Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
    J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21
    Oh SJ; Lee MG; Moon JR; Lee CK; Chi SG; Kim HJ
    J Gastroenterol Hepatol; 2019 May; 34(5):890-898. PubMed ID: 30226276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination.
    Yan J; Di Y; Shi H; Rao H; Huo K
    FEBS Lett; 2010 Oct; 584(20):4319-24. PubMed ID: 20849854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HEXIM1 as a positive regulator of p53.
    Lew QJ; Chia YL; Chu KL; Lam YT; Gurumurthy M; Xu S; Lam KP; Cheong N; Chao SH
    J Biol Chem; 2012 Oct; 287(43):36443-54. PubMed ID: 22948151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
    Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
    Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1).
    Dai C; Shi D; Gu W
    J Biol Chem; 2013 Jul; 288(27):19581-92. PubMed ID: 23677994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.
    Huang C; Wu S; Ji H; Yan X; Xie Y; Murai S; Zhao H; Miyagishi M; Kasim V
    Sci Adv; 2017 Oct; 3(10):e1701383. PubMed ID: 29057323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis.
    Wang J; Thomas HR; Li Z; Yeo NCF; Scott HE; Dang N; Hossain MI; Andrabi SA; Parant JM
    Cell Death Dis; 2021 Jun; 12(7):659. PubMed ID: 34193827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
    Xu C; Fan CD; Wang X
    Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression.
    Wang S; Sun W; Zhao Y; McEachern D; Meaux I; Barrière C; Stuckey JA; Meagher JL; Bai L; Liu L; Hoffman-Luca CG; Lu J; Shangary S; Yu S; Bernard D; Aguilar A; Dos-Santos O; Besret L; Guerif S; Pannier P; Gorge-Bernat D; Debussche L
    Cancer Res; 2014 Oct; 74(20):5855-65. PubMed ID: 25145672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of MdmX as a therapeutic target for reactivating p53 in tumors.
    Garcia D; Warr MR; Martins CP; Brown Swigart L; Passegué E; Evan GI
    Genes Dev; 2011 Aug; 25(16):1746-57. PubMed ID: 21852537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.